13-110683120-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024537.4(CARS2):​c.586G>A​(p.Asp196Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00176 in 1,595,142 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D196H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 51 hom. )

Consequence

CARS2
NM_024537.4 missense

Scores

8
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.67

Publications

6 publications found
Variant links:
Genes affected
CARS2 (HGNC:25695): (cysteinyl-tRNA synthetase 2, mitochondrial) This gene encodes a putative member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of cysteine to tRNA molecules. A splice-site mutation in this gene has been associated with a novel progressive myoclonic epilepsy disease with similar symptoms to MERRF syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]
CARS2 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 27
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01248005).
BP6
Variant 13-110683120-C-T is Benign according to our data. Variant chr13-110683120-C-T is described in ClinVar as Benign. ClinVar VariationId is 383497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0018 (2598/1442904) while in subpopulation SAS AF = 0.0191 (1600/83600). AF 95% confidence interval is 0.0184. There are 51 homozygotes in GnomAdExome4. There are 1715 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARS2NM_024537.4 linkc.586G>A p.Asp196Asn missense_variant Exon 6 of 15 ENST00000257347.9 NP_078813.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARS2ENST00000257347.9 linkc.586G>A p.Asp196Asn missense_variant Exon 6 of 15 1 NM_024537.4 ENSP00000257347.4

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
211
AN:
152120
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.0228
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0168
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000500
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00348
AC:
819
AN:
235382
AF XY:
0.00430
show subpopulations
Gnomad AFR exome
AF:
0.0000659
Gnomad AMR exome
AF:
0.000233
Gnomad ASJ exome
AF:
0.0201
Gnomad EAS exome
AF:
0.0000602
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000579
Gnomad OTH exome
AF:
0.00268
GnomAD4 exome
AF:
0.00180
AC:
2598
AN:
1442904
Hom.:
51
Cov.:
30
AF XY:
0.00239
AC XY:
1715
AN XY:
717370
show subpopulations
African (AFR)
AF:
0.0000621
AC:
2
AN:
32232
American (AMR)
AF:
0.000194
AC:
8
AN:
41214
Ashkenazi Jewish (ASJ)
AF:
0.0191
AC:
491
AN:
25732
East Asian (EAS)
AF:
0.0000261
AC:
1
AN:
38350
South Asian (SAS)
AF:
0.0191
AC:
1600
AN:
83600
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53082
Middle Eastern (MID)
AF:
0.00666
AC:
32
AN:
4802
European-Non Finnish (NFE)
AF:
0.000277
AC:
306
AN:
1104416
Other (OTH)
AF:
0.00266
AC:
158
AN:
59476
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
112
223
335
446
558
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00137
AC:
209
AN:
152238
Hom.:
2
Cov.:
33
AF XY:
0.00172
AC XY:
128
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41518
American (AMR)
AF:
0.000523
AC:
8
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0228
AC:
79
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0166
AC:
80
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000500
AC:
34
AN:
68012
Other (OTH)
AF:
0.00190
AC:
4
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00162
Hom.:
8
Bravo
AF:
0.000956
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.00370
AC:
449
Asia WGS
AF:
0.00779
AC:
27
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Combined oxidative phosphorylation defect type 27 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.5
L
PhyloP100
2.7
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.6
D
REVEL
Benign
0.18
Sift
Benign
0.12
T
Sift4G
Benign
0.11
T
Vest4
0.38
ClinPred
0.049
T
GERP RS
5.2
Varity_R
0.36
gMVP
0.85
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140082252; hg19: chr13-111335467; API